Internal Medicine, Pulmonary Disease · Clearwater, FL
NPI
1629005020
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
802 N Belcher Rd
Clearwater, FL, 33765
Phone (727) 447-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$200K
3,503 services
Medicare patients, 2024
692
Average age 75
Drug cost, 2024
$4.9M
6,407 prescriptions
Company payments, 2025
$102K
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francis J Averill was code 99214 (office e&m - established), 623 times for 337 patients. In total Francis J Averill billed 3,503 services in 66 codes, and Medicare paid $200K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 623 | 337 | $100.84 | $63K |
| 99213 Office E&M - Established | Office | 382 | 286 | $68.48 | $26K |
| 94010 Pulmonary Function Testing | Office | 243 | 214 | $20.98 | $5,098 |
| 99204 Office E&M - New | Office | 162 | 162 | $125.08 | $20K |
| 94060 Pulmonary Function Testing | Office | 118 | 111 | $29.08 | $3,431 |
| 94726 Pulmonary Function Testing | Office | 118 | 111 | $42.13 | $4,972 |
| 94729 Pulmonary Function Testing | Office | 118 | 111 | $42.98 | $5,072 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 110 | 18 | $0.77 | $84.46 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 110 | 18 | $0.09 | $10.02 |
| 99232 Hospital E&M - Subsequent | Facility | 107 | 31 | $61.50 | $6,580 |
| 96372 Injection Administration | Office | 100 | 24 | $11.35 | $1,135 |
| 99307 SNF E&M | Office | 87 | 19 | $31.61 | $2,750 |
| 99443 Telephone Services | Office | 73 | 52 | $92.72 | $6,768 |
| 99308 SNF E&M | Office | 69 | 20 | $58.55 | $4,040 |
| 94618 Pulmonary Function Testing | Office | 62 | 53 | $26.00 | $1,612 |
By year: 2022 $266K for 4,421 services; 2023 $253K for 4,208 services; 2024 $200K for 3,503 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francis J Averill prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 896 prescriptions and refills. In total Francis J Averill wrote 6,407 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 896 | 1,162 | 193 | $737K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 854 | 964 | 254 | $21K |
| Montelukast Sodium Generic | 595 | 1,379 | 167 | $5,537 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 402 | 467 | 95 | $289K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 243 | 282 | 51 | $129K |
| Breo Ellipta Fluticasone/Vilanterol | 223 | 285 | 50 | $112K |
| Fluticasone Propionate Generic | 212 | 390 | 82 | $3,577 |
| Prednisone Generic | 194 | 229 | 102 | $603 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 166 | 204 | 46 | $20K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 163 | 255 | 59 | $21K |
| Azithromycin Generic | 132 | 172 | 63 | $3,033 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 117 | 173 | 33 | $80K |
| Spiriva Respimat Tiotropium Bromide | 95 | 129 | 19 | $67K |
| Modafinil Generic | 89 | 109 | 17 | $20K |
| Ventolin Hfa Albuterol Sulfate | 89 | 97 | 43 | $5,540 |
Brand drugs: 3,488 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francis J Averill $102K ($102K in general payments such as food, travel and fees) from 31 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $95K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 108 | $95K |
| Mannkind Corporation MNKD | 1 | $3,150 |
| GlaxoSmithKline, LLC. GSK | 21 | $445 |
| Harmony Biosciences LLC HRMY | 11 | $350 |
| Jazz Pharmaceuticals Inc. JAZZ | 8 | $283 |
| Insmed, Inc. INSM | 11 | $272 |
| Mallinckrodt Hospital Products Inc. | 8 | $239 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $225 |
| Amgen Inc. AMGN | 10 | $212 |
| Abbott Laboratories ABT | 3 | $191 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.